(Q29037307)

https://doi.org/10.1016%2FS0140-6736%2896%2903430-7

27 March 2017

0 references

1 reference

1 reference

Ole Kronborg

1 reference

https://doi.org/10.1016%2FS0140-6736%2896%2903430-7

27 March 2017

Claus Fenger

1 reference

https://doi.org/10.1016%2FS0140-6736%2896%2903430-7

27 March 2017

Jørn Olsen

1 reference

https://doi.org/10.1016%2FS0140-6736%2896%2903430-7

27 March 2017

Ole Dan Jørgensen

1 reference

https://doi.org/10.1016%2FS0140-6736%2896%2903430-7

27 March 2017

Ole Søndergaard

1 reference

https://doi.org/10.1016%2FS0140-6736%2896%2903430-7

27 March 2017

language of work or name

English

0 references

publication date

November 1996

1 reference

https://doi.org/10.1016%2FS0140-6736%2896%2903430-7

27 March 2017

1 reference

https://doi.org/10.1016%2FS0140-6736%2896%2903430-7

27 March 2017

volume

348

1 reference

https://doi.org/10.1016%2FS0140-6736%2896%2903430-7

27 March 2017

issue

9040

1 reference

https://doi.org/10.1016%2FS0140-6736%2896%2903430-7

27 March 2017

page(s)

1467-1471

1 reference

https://doi.org/10.1016%2FS0140-6736%2896%2903430-7

Effect of fecal occult blood testing on mortality from colorectal cancer. A case-control study

27 March 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903430-7

7 January 2021

Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903430-7

7 January 2021

Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903430-7

7 January 2021

Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903430-7

7 January 2021

Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903430-7

7 January 2021

Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903430-7

7 January 2021

Acceptability and compliance in screening for colorectal cancer with fecal occult blood test

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903430-7

7 January 2021

Biometric design of the mayo lung project for early detection and localization of bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903430-7

7 January 2021

Causes of Death during the First 5 Years of a Randomized Trial of Mass Screening for Colorectal Cancer with Fecal Occult Blood Test

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903430-7

7 January 2021

Adenomas and hyperplastic polyps in screening studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903430-7

7 January 2021

Participation in mass screening for colorectal cancer with fecal occult blood test

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2896%2903430-7

7 January 2021